º¸·ÉÁ¦¾à, µ¿È¾àǰ°ú Ä«³ªºê ÀÌ´¢ º¹ÇÕÁ¦ °øµ¿°³¹ß ±â¼ú Á¦ÈÞ
|
º¸·ÉÁ¦¾àÀº µ¿È¾àǰ°ú Ä«³ªºê ÀÌ´¢ º¹ÇÕÁ¦ °øµ¿°³¹ß¿¡ ´ëÇÑ ±â¼úµµÀÔ, ÀÌÀü, Á¦ÈÞ¿¡ ´ëÇÑ °è¾àÀ» ü°áÇß´Ù°í 29ÀÏ °ø½Ã¸¦ ÅëÇØ ¹àÇû´Ù.
À̹ø °è¾à ü°á·Î ȸ»ç.. ´º½º¿ÂÇÇÇà | 11-29 09:36 |
|
|
|
DPP-4 ¾ïÁ¦Á¦ Æ®¶óÁ¨Å¸ 'CAROLINA' Àӻ󿬱¸ ȯÀÚ µî·Ï ¿Ï·á
|
Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓ(´ëÇ¥: ´õÅ© ¹ê ´ÏĿũ)°ú Çѱ¹¸±¸®(´ëÇ¥: Æú Ç ÈÞ¹ö½º)´Â Á¦ 2Çü ´ç´¢º´ Ä¡·áÁ¦ÀÎ Æ®¶óÁ¨Å¸(¼ººÐ¸í: ¸®³ª±Û¸³Æ¾)ÀÇ ½ÉÇ÷°ü°è ¾ÈÀü¼º ÀÔÁõ.. ´º½º¿ÂÇÇÇà | 11-27 11:33 |
|
|
|
Çѱ¹ÈÀÌÀÚÁ¦¾à, 2012 PRIME ½ÉÆ÷Áö¾ö ¼º·á
|
Çѱ¹ÈÀÌÀÚÁ¦¾àÀº Ãֱ٠ȣÈí±â³»°ú ÁßȯÀÚ ÀÇÇÐ Àü¹®ÀǸ¦ ´ë»óÀ¸·Î ÇÑ '2012 PRIME' ½ÉÆ÷Áö¾öÀ» ¼ºÈ²¸®¿¡ ¸¶ÃÆ´Ù°í 27ÀÏ ¹àÇû´Ù.
À̹ø ½ÉÆ÷Áö¾ö¿¡¼´Â ÃÖ±Ù Áß.. ´º½º¿ÂÇÇÇà | 11-27 11:17 |
|
|
|
»ç³ëÇÇ, ±¹³» ¹ÙÀÌ¿À º¥Ã³ ÆÄ¸ã½Å¡¤ANRT¿Í °øµ¿¿¬±¸ °è¾à ü°á
|
»ç³ëÇÇ-¾Æº¥Æ¼½º ÄÚ¸®¾Æ(´ëÇ¥ÀÌ»ç Àå ¸¶¸® ¾Æ¸£³ë)´Â ±¹³» ¹ÙÀÌ¿Àº¥Ã³ ±â¾÷ÀÎ ÆÄ¸ã½Å(´ëÇ¥ÀÌ»ç À¯Áø»ê), ANRT(´ëÇ¥ ¼º°æ¹Ì)¿Í Ç×ü ½Å¾àÈĺ¸ ¹°Áú ¹ß±¼À» À§ÇÑ °ø.. ´º½º¿ÂÇÇÇà | 11-27 10:54 |
|
|
|
Á¦1ȸ Çѱ¹ÇコĿ¹Â´ÏÄÉÀ̼ÇÇÐȸ¡¤¿£ÀÚÀÓ Çмú»ó ¹ßÇ¥
|
Çѱ¹ÇコĿ¹Â´ÏÄÉÀ̼ÇÇÐȸ(ȸÀå À̱ͿÁ, ¼¼Á¾´ë ½Å¹®¹æ¼ÛÇаú ±³¼ö)¿Í ÇコÄɾî Àü¹® ÄÁ¼³ÆÃ»ç ¿£ÀÚÀÓ(´ëÇ¥ ±èµ¿¼®)ÀÌ °øµ¿ Á¦Á¤ÇÑ 'Á¦1ȸ Çѱ¹ÇコĿ¹Â´ÏÄÉÀ̼Ç.. ´º½º¿ÂÇÇÇà | 11-27 09:34 |
|
|
|
|
 |
Çö´ë¾àǰ, '¿¹»Û ´« ¼±¹ß´ëȸ' ½Ã»ó½Ä °³ÃÖ
|
Çö´ë¾àǰÀº Áö³ 21ÀÏ ´«½Î¿òºò¸®±× ½ÃÁð2-Ä·ÆÛ½º¾îÅà '¿¹»Û ´« ¼±¹ß´ëȸ'ÀÇ ½Ã»ó½ÄÀ» ÁøÇàÇß´Ù°í 26ÀÏ ¹àÇû´Ù.
´«½Î¿òºò¸®±×´Â ´«À» ¹Ù¸£°Ô º¸È£ÇÏ´Â ¹æ¹ýÀ».. ´º½º¿ÂÇÇÇà | 11-26 20:34 |
|
|
|
|
Çѱ¹¾àÁ¦ÇÐȸ, ⸳ 42Áֳ⠱â³ä ±¹Á¦Çмú´ëȸ °³ÃÖ
|
Çѱ¹¾àÁ¦ÇÐȸ(ȸÀå ÃÖ¿µ¿í)´Â ¿À´Â 29~30ÀÏ ±¤ÁÖ È¦¸®µ¥ÀÌÀΠȣÅÚ¿¡¼ '±Û·Î¹ú ÷´Ü Á¦Á¦ ±â¼ú(Global Cutting-Edge Technology in Pharmaceutical Sciences)'À».. ´º½º¿ÂÇÇÇà | 11-26 20:32 |
|
|
|
|
|
 |
Çö´ë¾àǰ, Å»¸ð¿¹¹æ °¿¬È¸ 'ÅÐÅб³½Ç' °³ÃÖ
|
Çö´ë¾àǰÀº Áö³ 21ÀÏ °æ±âµµ ÀÏ»ê °üµ¿ÀÇ´ë ¸íÁöº´¿ø¿¡¼ Áö¿ªÁֹΠ¹× º´¿ø ÀÇ·áÁø°ú ȯÀÚ¸¦ ´ë»óÀ¸·Î Å»¸ð¿¹¹æ »çȸ°øÇå °¿¬È¸ 'ÅÐÅб³½Ç'À» °³ÃÖÇß´Ù°í 23ÀÏ.. ´º½º¿ÂÇÇÇà | 11-23 16:32 |
|
|
|
|
½ÅÁ¾ ¸¶¾à·ù ´ë¿ë¹°Áú '4-MA, 4-FA' Àӽø¶¾à·ù ÁöÁ¤
|
½ÄǰÀǾàǰ¾ÈÀüûÀº ÃÖ±Ù À¯·´ µî¿¡¼ ¸¶¾à·ù ´ë¿ëÀ¸·Î ºÒ¹ý »ç¿ëµÇ°í ÀÖ´Â ÁßÃ߽Űæ ÈïºÐ ¼ººÐÀÎ ¾ÏÆäŸ¹Î À¯»ç¹°Áú 4-¸ÞÆ¿¾ÏÆäŸ¹Î(4-Methylamphetamine, 4-MA)°ú.. ´º½º¿ÂÇÇÇà | 11-23 12:05 |
|
|
|
½Ä¾àû, ¼º±Õ°ü´ë¿Í ¾çÇØ°¢¼ ü°á¡¦Á¦¾à Àü¹®Àη ¾ç¼º ±âƲ ¸¶·Ã
|
½ÄǰÀǾàǰ¾ÈÀüûÀº 23ÀÏ ¼¿ï ¸í·ûµ¿ ¼ÒÀç ¼º´ë 600Áֳ⠱â³ä°ü¿¡¼ ±¹³» Á¦¾à»ê¾÷ Àü¹®Àη ¾ç¼ºÀÇ ±âƲÀ» ¸¶·ÃÇϰíÀÚ ¾÷¹«Çù¾à(MOU)À» ü°áÇÑ´Ù°í ¹àÇû´Ù.
ÀÌ.. ´º½º¿ÂÇÇÇà | 11-23 11:21 |
|
|
|
´ç´¢º´Ä¡·áÁ¦ Æ®¶óÁ¨Å¸µà¿À, ½Ä¾àû Çã°¡ ȹµæ
|
Â÷¼¼´ë DPP-4 ¾ïÁ¦Á¦ Æ®¶óÁ¨Å¸¿Í ¸ÞÆ®Æ÷¸£¹Î º¹ÇÕÁ¦ÀÎ ´ç´¢º´Ä¡·áÁ¦ Æ®¶óÁ¨Å¸µà¿À°¡ ÃÖ±Ù ½Ä¾àû Çã°¡¸¦ ȹµæÇØ ´ç´¢º´ ȯÀÚÀÇ Ä¡·á°³¼±¿¡ º¸´Ù ³ªÀº È¿°ú¸¦ ±â´ë.. ´º½º¿ÂÇÇÇà | 11-23 10:31 |
|
|
|
|
|
»ç³ëÇÇ '¸¯½Ã¼¼³ªÅ¸À̵å', À¯·´ÀǾàǰû¼ ±àÁ¤Àû ÀÇ°ß ¹Þ¾Æ
|
»ç³ëÇÇ´Â À¯·´ÀǾàǰû »êÇÏ ¾à¹°»ç¿ëÀÚ¹®À§¿øÈ¸(CHMP)·ÎºÎÅÍ 1ÀÏ 1ȸ Åõ¿©ÇÏ´Â »õ·Î¿î °è¿ÀÇ ´ç´¢º´ Ä¡·áÁ¦ÀÎ ¸¯½Ã¼¼³ªÅ¸À̵å(Lixisenatide)ÀÇ À¯·´ ³» »ç¿ë¿¡.. ´º½º¿ÂÇÇÇà | 11-21 11:12 |
|
|
|
<ºÎ°í> ¹ÚÇü½Ä(»ïÁøÁ¦¾à ¹ß¼Û°ú °úÀå)¾¾ ºÎÄ£»ó
|
¹ÚÇü½Ä(»ïÁøÁ¦¾à ¹ß¼Û°ú °úÀå)¾¾ ºÎÄ£»ó = 21ÀÏ, °µ¿±¸ º¸Èƺ´¿øÀå·Ê½ÄÀå 5È£½Ç, ¹ßÀÎ 22ÀÏ, ¿¬¶ôó(02-2225-1444). ´º½º¿ÂÇÇÇà | 11-21 09:33 |
|
|
|
¿°»ö¾à »ç¿ëÀÚ 4¸íÁß 1¸í²Ã ºÎÀÛ¿ë ÀÏÀ¸ÄÑ
|
¸Ó¸®¿°»öÀ» ÇÏ´Â »ç¶÷µé °¡¿îµ¥ 4¸íÁß 1¸íÀÌ ¿°»ö¾àÀ¸·Î ÀÎÇØ ºÎÀÛ¿ëÀ» °æÇèÇϰí ÀÖ´Ù´Â Á¶»ç°á°ú°¡ ³ª¿Ô´Ù.
°¡Å縯ÀÇ´ë ¼º¹Ù¿À·Îº´¿ø °ÈÆ ÇǺΰú ±³¼ö´Â .. ´º½º¿ÂÇÇÇà | 11-21 12:31 |
|
|
|
Çѱ¹¾Æ½ºÆ®¶óÁ¦³×Ä«, 'À§½Äµµ¿ª·ùÁúȯ ±æµéÀ̱â' °Ç°°ÁÂ
|
Çѱ¹¾Æ½ºÆ®¶óÁ¦³×Ä«(´ëÇ¥ ¹Ú»óÁø)´Â À§½Äµµ¿ª·ùÁúȯÀÇ ÀνÄÀ» ÁõÁø½ÃŰ°í ¿Ã¹Ù¸¥ Áúȯ Á¤º¸¸¦ Àü´ÞÇϰíÀÚ À§½Äµµ¿ª·ùÁúȯ °Ç°°Á¸¦ ÁøÇàÇÑ´Ù°í 20ÀÏ ¹àÇû´Ù.
.. ´º½º¿ÂÇÇÇà | 11-20 11:59 |
|
|
|